Prolonged partial upper airway obstruction during sleep – an underdiagnosed phenotype of sleep-disordered breathing

REVIEW ARTICLE

Prolonged partial upper airway obstruction during sleep – an underdiagnosed phenotype of sleep-disordered breathing

Ulla Anttalainen1,2,3*, Mirja Tenhunen4,5, Ville Rimpilä6, Olli Polo7,8, Esa Rauhala9, Sari-Leena Himanen4,6 and Tarja Saaresranta1,2,3

1Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland; 2Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland; 3Sleep Research Centre, Department of Physiology, University of Turku, Turku, Finland; 4Department of Clinical Neurophysiology, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Tampere University Hospital, Tampere, Finland; 5Department of Medical Physics, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Tampere University Hospital, Tampere, Finland; 6School of Medicine, University of Tampere, Tampere, Finland; 7Unesta Research Center, Tampere, Finland; 8Department of Pulmonary Diseases, Tampere University Hospital, Tampere, Finland; 9Department of Clinical Neurophysiology, Satakunta Hospital District, Pori, Finland

Abstract

Obstructive sleep apnea syndrome (OSAS) is a well-recognized disorder conventionally diagnosed with an elevated apnea–hypopnea index. Prolonged partial upper airway obstruction is a common phenotype of sleep-disordered breathing (SDB), which however is still largely underreported. The major reasons for this are that cyclic breathing pattern coupled with arousals and arterial oxyhemoglobin saturation are easy to detect and considered more important than prolonged episodes of increased respiratory effort with increased levels of carbon dioxide in the absence of cycling breathing pattern and repetitive arousals. There is also a growing body of evidence that prolonged partial obstruction is a clinically significant form of SDB, which is associated with symptoms and co-morbidities which may partially differ from those associated with OSAS. Partial upper airway obstruction is most prevalent in women, and it is treatable with the nasal continuous positive pressure device with good adherence to therapy. This review describes the characteristics of prolonged partial upper airway obstruction during sleep in terms of diagnostics, pathophysiology, clinical presentation, and comorbidity to improve recognition of this phenotype and its timely and appropriate treatment.

Keywords: prolonged partial upper airway obstruction; flow limitation; increased respiratory resistance; non-apneic snoring; simple snoring; sleep; sleep apnea; UARS

Citation: European Clinical Respiratory Journal 2016, 3: 31806 - http://dx.doi.org/10.3402/ecrj.v3.31806

Responsible Editor: Eva Lindberg, Uppsala University, Sweden.

Copyright: © 2016 Ulla Anttalainen et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.

Received: 1 April 2016; Accepted: 10 August 2016; Published: 6 September 2016

Competing interests and funding: Dr. Anttalainen reports personal fees from ResMed Finland, grants from Turku University Hospital Governmental Grant, Respiratory Alliance Foundation, and Finnish Anti-Tuberculosis Association Foundation, outside the submitted work. Dr. Saaresranta reports personal fees from ResMed Finland, grants from Turku University Hospital Governmental Grant, Paulo Foundation, Rauha and Jalmari Ahokas Foundation, Finnish Anti-Tuberculosis Association Foundation, and Respiratory Alliance Foundation, outside the submitted work. She is the President of the Task Force for National Guidelines for Adult Sleep Apnoea. Dr. Olli Polo runs a private clinic Unesta specializing in sleep disorders. He reports grants from Tampere Tuberculosis Foundation. The other authors have nothing to disclose.

*Correspondence to: Ulla Anttalainen, Sleep Research Center, Lemminkäisenkatu 3B, 20520 Turku, Finland, Email: ulla.anttalainen@tyks.fi

 

Obstructive sleep apnea syndrome (OSAS) is a common clinical disorder, which is associated with a reduced quality of life, as well as significant comorbidity and mortality (15). In spite of the growing knowledge that upper airway obstruction during sleep may be either complete or partial and prolonged, nearly all studies use apnea–hypopnea index (AHI) to classify the severity of sleep-disordered breathing (SDB). AHI measures the frequency of periodic obstructive or central events per hour of sleep. Identification of apneic events as obstructive, central or mixed relies on strain gauges, oronasal thermistors or monitoring inspiratory flow via nasal pressure transducer (6). The AHI has been criticized for 30 years for oversimplification of SDB (7). Prolonged upper airway obstruction or increased respiratory resistance (IRR) without significant hypopnea or desaturation is not considered. This may result in ignorance of a significant time of the recordings when the subject increases his or her respiratory efforts to fight against prolonged partial upper airway obstruction. It is known that prolonged partial upper airway obstruction may result in daytime symptoms and increase the risk of developing high blood pressure by 42% even if AHI remains normal (811). Partial upper airway obstruction is the most common form of SDB in females (10, 12, 13). It is important to recognize partial upper airway obstruction and agree about the standards of its assessment in order to build sufficient body of evidence for the pathophysiological and clinical significance of this phenotype of SDB.

Partial upper airway obstruction is underrepresented in the literature for many reasons. First, there is no consensus of its detection, quantification or clinical impact. Second, episodes of partial upper airway obstruction are usually prolonged, typically for several minutes, and the severity of which cannot be defined on an event basis [as is done with AHI or respiratory disturbance index (RDI)]. Since patients with prolonged partial upper airway obstruction may have low AHI, it is commonly interpreted as mild sleep apnea, not warranting treatment. Third, partial upper airway obstruction is associated with increased partial pressure of carbon dioxide (CO2) (14, 15), which is rarely measured in the context of a sleep study. Finally, part of the ignorance can be attributed to the fact that arousals during partial obstruction are not as frequent as they are during repetitive episodes of sleep apnea (16). Despite the lack of solid correlation between the arousal frequency and excessive sleepiness (17), the cardinal symptom of SDB, other mechanisms than arousals or sleep fragmentation is rarely considered behind sleepiness. There is an urgent need to recognize partial obstruction as a treatable form of SDB in order to understand why certain patients with low AHI may still suffer from symptoms and benefit from appropriate intervention. This review is aiming to increase awareness and recognition of prolonged, sustained partial upper airway obstruction during sleep as a phenotype of SDB.

Pathophysiology of prolonged partial upper airway obstruction

The upper airway is often modeled as a collapsible tube, the patency of which is critically dependent on the upper airway dilator muscle tone (18). Transition from wakefulness to sleep is associated with decreasing sympathetic tone (19) and decreasing upper airway muscle tone (20) and increased upper airway resistance (21), which are the reasons why SDB is sleep state dependent. Normally, simultaneously decreasing sympathetic activity allows for a physiologic increase in CO2, which has a stabilizing effect on the upper airway (22). In other words, in healthy individuals, during transition from wakefulness to sleep, the upper airway dilating forces shift from the muscle tone of wakefulness to muscle support by physiologically increased levels of CO2 occurring during stable sleep.

In patients with obstructive sleep apnea or hypopnea, this upper airway stabilizing process of increasing CO2 level is repetitively interrupted. Structurally too-narrow airways may collapse completely, and an arousal is required to restore the sympathetic tone and upper airway muscle tone. This results in hyperventilation, decreased levels of CO2, instability of the upper airway and instability of the breathing pattern (cyclic breathing). The repetitive pattern allows for counting the events per hour (apnea index, AHI or RDI).

During prolonged partial upper airway obstruction, the inspiratory duty cycle (Ti/Ttot) is prolonged (2325) and breathing frequency increased (23). Arousals are less frequent during sleep induction, which allows for CO2 to increase until stable sleep is established. If the upper airway still remains partially obstructed, stability between the collapsing and dilating forces may lead to CO2 increase at much higher levels than would be optimal for the system during sleep [the plateau concept (26)]. As a result, the intensity of respiratory effort and the intrathoracic pressure swings may increase in a crescendo pattern until stabilizing for long periods above the optimal level of CO2 during sleep or terminating in arousal.

Collapsible properties as well as neuromuscular responses of the upper airway have been studied by applying negative pressure to the upper airway and determining the critical closing pressure (Pcrit) (18, 27, 28). It has been suggested that the upper airway collapsibility is a continuum from normal breathing to snoring, hypopnea and finally apnea and that it associates with increasing Pcrit (28). A recent study showed that Pcrit and genioglossus muscle activity are sleep stage dependent and that muscle activity is greatest during slow-wave sleep (SWS) (20). OSA patients and non-apneic snorers have also an increased threshold for detecting vibration in the upper airway which could predispose upper airway obstruction (29). This impairment is partially reversible with continuous positive airway pressure (CPAP), suggesting that upper airway sensory function deteriorates as the disease progress.

Prolonged partial upper airway obstruction represents a situation where balance is established between collapsing and dilating forces. This compensation however is not complete. It is sufficient enough to prevent the development of hypoxia to a level which would strongly stimulate the breathing, but few studies have shown that these episodes associate with increased CO2 levels (14, 15, 25, 30) suggesting insufficient compensation regarding the CO2 (Fig. 1). In a recent study inspiratory flow limitation episodes were associated with 0.2 kPa PtcCO2 increase from normal breathing levels (15). Study by Lo et al. (22) showed that when inspiratory CO2 is increased (5 or 10 mmHg) above the eupneic level, increase in genioglossus EMG activity is observed. Unloading the upper airway with CPAP did not alter the slope of genioglossus activity although the overall activity was lower. This implies that both chemoreceptor as well as negative pressure reflex modulates the upper airway patency.

Fig 1

Fig. 1.   Example of overnight PtcCO2 and SaO2 profile with expanded view of normal steady breathing, prolonged flow limitation and hypopnea sequence. Note the association between breathing type and PtcCO2 (15). (Reproduced with permission from Respir Physiol Neurobiol). PtcCO2=transcutaneous carbon dioxide; SaO2=arterial oxyhemoglobin saturation.

Diagnostics of prolonged partial upper airway obstruction during sleep

Upper airway dysfunction during sleep has been described with variable terminology in the literature (Table 1). Standardized diagnostic criteria for prolonged partial upper airway obstruction do not exist. In clinical practice, periods longer than hypopnea (minimum 1–3 min) are often used as indicative of sustained upper airway resistance (10, 31). During partial obstruction breathing, effort prevails against partially closed upper airway resulting in diminished airflow, which can be measured reliably by pneumotachograph. Even if it is a valid method to quantify partial obstruction, nasal prongs or cannula revealing inspiratory flow limitation are often used as a surrogate of the pneumotachographic signal in clinical sleep studies. Measuring increasing effort provides another reliable means to evaluate the increased resistance. The golden standard to assess inspiratory effort is measuring esophageal pressure (pESO) (6). In pESO signal the prolonged partial obstruction induces episodes of sustained increased negativity without periodic arousals (Fig. 2). The pattern is clearly distinguishable from the periodic pESO swings, which terminate in arousals and are related to apneas, hypopneas and UARS (Upper Airway Resistance Syndrome) events. However, the pressure catheter is often considered uncomfortable and in clinical work indirect, non-invasive methods are preferred.

Fig 2

Fig. 2.   Example of a 5-min polysomnography period. At the beginning of the sheet, respiratory movements are stable; flow channel shows slight flow limitation and mouth breathing. Negative esophageal pressure is increased up to −30 cm H2O. Emfit high-frequency channel shows multiple spikes. At the middle of sheet (marked with a black arrow) is a short arousal with opening of upper airway, normalizing esophageal pressure values and cease of spiking. Gradually breathing effort starts to increase again. Channels from top: thoracic and abdominal belts, flow by nasal pressure transducer, esophageal pressure, Emfit high-frequency channel, Emfit low-frequency channel, arterial oxyhemoglobin saturation, snoring, and pulse.


Table 1.  Definitions and special characteristics of the various terminologies that have been used to describe upper airway dysfunction during sleep
      Prolonged partial obstruction
  OSA UARS IRR Flow limitation
Key sensors Thermistors, nasal prongs connected to pressure transducer and thoracic/abdominal belts Esophageal pressure catheter and polysomnography (RERAs with EEG) Sleep mattress and esophageal pressure Nasal prongs connected to pressure transducer
Patient’s respiratory efforts Periodic breathing (periodic increases in respiratory efforts) Increased for few breaths Increased for prolonged periods (1 to over 60 min) Normal or increased
Arousals Repetitive Repetitive, terminate each event Terminates episodes, association to respiration unambiguous May terminate episodes
SaO2 Repetitive dips No change No change or slow desaturation No change or slow desaturation
CO2 Oscillation No change Gradual retention No change or gradual retention
OSA=obstructive sleep apnea, UARS=upper airway resistance syndrome, IRR=increased respiratory resistance, RERA=respiratory effort-related arousal, EEG=electroencephalogram, SaO2=arterial oxygen saturation, CO2=carbon dioxide.

In routine clinical polysomnography (PSG) the nasal pressure transducer signal provides an easy method to evaluate the amount of prolonged partial obstruction. Non-round, flattened inspiratory flow shape in nasal prongs signal is indicative to partial collapse in the upper airway (3236). This flow limitation pattern is normally present during UARS events and hypopneas, when it is associated with frequent arousals (37). However, it also appears in prolonged periods up to several minutes (38). As flow limitation is associated with increasing negativity in pESO (39) and nasal pressure signal strongly correlates with pneumotachograph (40), it seems reliable to detect prolonged partial upper airway obstruction by nasal prongs. However, flow limitation may exist without upper airway obstruction (32) and vice versa (16). In addition, in some cases nasal prongs may even increase upper airway resistance (41). To conclude, flow limitation measured with nasal prongs is suggestive, but not a fully reliable marker of increased effort.

Particularly in the clinical PSG of children, prolonged partial obstruction is often detected by the surface electromyography (EMG) of the diaphragm and intercostal muscles, which seems to reflect changes in respiratory effort (42). However, frequent technical problems limit the use of EMG in assessing respiratory effort (43). There are no studies evaluating the usefulness of inductive belts in the diagnostics of prolonged partial obstruction. The method requires frequent calibration when position changes, which restrict its use (43, 44). Prolonged partial obstruction is usually associated with sustained crescendo snoring. Using a snoring signal to assess prolonged partial obstruction is, however, problematic, since there is no means to differentiate between benign snoring and snoring associated with marked partial obstruction.

Non-invasive techniques of measuring respiratory effort were reviewed recently by Vandenbussche et al. (45), but in Finland in conjunction with conventional sensors the most used sensors in detecting prolonged partial upper airway obstruction are mattress sensors: Static Charge Sensitive Bed (SCSB) and Electromechanical film transducer (Emfit) (46). In SDB diagnostics raw mattress signal reveals gross body movements. The low-frequency band (0.3–10 Hz) visualizes breathing movements, and the high-frequency band (6–16 Hz) shows heart activity and high-frequency spikes. Experimentally these spikes are shown to correlate with increasing respiratory effort (47).

The mattress breathing categories are visually scored by the three mattress channels. The categories with high-frequency spikes represent increased respiratory effort (10, 16). Normal breathing consists of regular breathing movements with no flow limitation, no high-frequency spikes and mostly normal pESO values. Obstructive periodic breathing is composed of periodic fluctuation of respiratory movements with periodically emerging high-frequency spikes and periodic pESO swings. Flow signal shows periodic respiratory events (apneas and hypopneas). IRR pattern represents prolonged partial upper airway obstruction. IRR consists of regular respiratory movements with sustained high-frequency spikes and sustained negative increase in the pESO signal (Fig. 2). Flow limitation pattern is commonly seen in the flow channel.

In clinical practice, PSG is not needed to detect partial upper airway obstruction. Periods longer than hypopnea (minimum 1–3 min) are used as indicative of sustained upper airway resistance. Prolonged partial obstruction is usually associated with sustained crescendo snoring. Combining these two key factors, measuring the flow limitation with nasal prongs and using snoring signal, together gives a reliable marker of prolonged partial obstruction (10, 15, 48). Key features of prolonged partial upper airway obstruction during sleep are presented in Table 2.


Table 2.  Clinical key features of prolonged partial upper airway obstruction
Key features of prolonged partial upper airway obstruction
Definition criteria – Prolonged flow limitation for more than 20–30% of TIB or TST
  – Crescendo snoring
  – CO2 increase during sleep >6 kpa
  – Absence of repetitive arousals
Diagnostic findings – Sustained flow limitation in nasal prongs
  – Increased respiratory effort (Emfit mattress signal, inductive plethysmography, esophageal pressure)
  – Crescendo snoring
Populations at risk – Children
  – Females
  – Postmenopausal women
  – Patients with symptoms of SDB but with low AHI
  – Patients on antipsychotic therapy gaining weight
Symptoms – Fatigue>sleepiness
  – Depressive symptoms
  – Morning headache
  – Decreased quality of life
  – Similar comorbidity as in SDB with high AHI
Treatment options – CPAP
  – Mandibular advancement devices in supine position-dependent partial obstruction
  – Surgery unlikely to work
AHI=apnea–hypopnea index, CPAP=continuous positive airway pressure, CO2=carbon dioxide, SDB=sleep-disordered breathing, TIB=time in bed, TST=total sleep time.

Clinical presentation

Prevalence of prolonged partial upper airway obstruction

The prevalence of prolonged upper airway obstruction during sleep is not known. Short UARS events have been shown to represent only 5.3% of all obstructive non-apneic events in patients with moderate OSA (49). Based on limited number of small studies, prolonged upper airway obstruction seems to be more common than classical OSAS and have female predominance. Comparing 233 age- and body mass index (BMI)-matched male–female pairs with suspected OSAS, prolonged partial upper airway obstruction was the most common single breathing abnormality, accounting for half of all observed breathing abnormalities in women compared to only one third in men (12). From 157 consecutive patients referred to full PSG 29.9% presented with OSA, whereas 10.8% had prolonged partial obstruction with normal AHI (10). The proportion of females was higher in patients with prolonged partial obstruction as compared with OSA patients (47 and 17% females, respectively). In healthy postmenopausal women, the prevalence of partial upper airway obstruction was 10 times higher (17.7%) compared with that of frank OSA (1.6%) (13). In a clinical sample of pre- and postmenopausal women, the prevalence of SDB was 79.4 and 86.2%, respectively (31). The prevalence of frank obstructive sleep apnea did not differ, whereas partial upper airway obstruction was more prevalent in postmenopausal (66.1%) than in premenopausal (50.9%) women (31). A cross-sectional cohort study showed that in the ‘normal’ asymptomatic population the percentage of total sleep time with flow limitation is less than 30% in 95% of the population (50).

In the clinical sleep laboratory population, 10% had only partial upper airway obstruction and another 8% had OSA plus partial upper airway obstruction (10). In another clinical sleep laboratory population comparing age- and BMI-matched male–female pairs, women had 10.5% and men had 7.5% of partial upper airway obstruction (51).

Symptoms and signs

In sleep studies, compared to men, women have lower AHI (52). Women with sleep apnea are frequently symptomatic with low AHI (53). This suggests that factors other than the AHI are likely to contribute to the symptoms of SDB among women. Lower AHI in women is contrasted with higher occurrence of prolonged partial upper airway obstruction (13, 31, 54, 55) which usually appears in SWS and is associated with elevated CO2 levels (14, 26). Increased CO2 during sleep might explain gender differences in symptom and comorbidity profiles (56, 57). This is supported by findings that excessive daytime sleepiness and daytime fatigue associate with habitual snoring independent of age, obesity, smoking, AHI, and sleep parameters in women (58). In a retrospective study of 240 women no difference was observed in terms of sleepiness or other symptoms between women with partial upper airway obstruction or classical obstructive sleep apnea (59). Sleep laboratory patients with prolonged partial obstruction had decreased life quality score as compared with OSA patients (10). Micrognathia was more common in women with partial upper airway obstruction compared to those with OSA (59).

Impact of age and obesity

Prevalence of OSAS increases with age and obesity. In a study of 233 age- and BMI-matched male–female pairs, classical sleep apnea increased with increasing BMI only in men, whereas partial obstruction increased with moderate to morbid obesity in both genders after the age of 65 years (Fig. 3) (51). In women, increasing age was also associated with an increase in prolonged partial obstruction and showed tendency also in men (Fig. 3). These findings suggest that men have a gender-specific BMI-dependent predisposition for periodic obstruction, that is, classical OSA, which is likely to reflect gender differences in the ventilatory and upper airway control during sleep or in the arousal threshold. Moreover, AHI is likely to underestimate the impact of SDB especially in elderly patients.

Fig 3

Fig. 3.   The three-dimensional figures demonstrate that the associations are non-linear and suggest that in women (left-hand panel) there is a consistently increasing susceptibility for prolonged partial upper airway obstruction after 65 years of age over the entire BMI range, whereas in men (right-hand panel) partial obstruction associates with the combination of high age–high BMI (51). (Reproduced with permission from Respir Physiol Neurobiol).

Respiratory instability predisposes to periodic upper airway obstruction whereas stable breathing underlies partial obstruction. Hormonal changes at menopause may stabilize control of breathing, whereas increasing obesity could predispose to respiratory instability because of increasing sympathetic activity and carotid body gain (60).

Comorbidity

Mild OSA in terms of AHI may not translate into less severe health consequences than OSA with higher AHI (11, 59, 61). Episodes of prolonged partial upper airway obstruction are associated with increased intrathoracic pressure variation (16) and increased CO2 level (14), indicating increased respiratory efforts and respiratory workload. Partial upper airway obstruction may be one important factor in the development of hypercapnic respiratory failure (62).

Case series suggest that hypertension might be a consequence of untreated partial obstruction (63, 64). In a study of 133 women and 122 men, reimbursed medication for hypertension was used three times more often in patients with partial obstruction compared with those with frank OSA (65). However, other co-morbidities with reimbursed medication did not differ between patients with partial obstruction compared with those with frank OSA except for asthma and/or COPD which was more prevalent among patients with partial obstruction (65). This indicates similar comorbidity in patients with prolonged partial upper airway obstruction and in those with OSA. On the other hand, the same study found a lower risk for hypertension in postmenopausal women presenting with predominantly partial upper airway obstruction compared with those with classical OSA (65). This is supported by diminished sympathetic tone measured with heart rate variability in IRR compared with OSAS patients (66).

In women with pre-eclampsia, SDB typically manifests as flow limitation with increased nocturnal CO2 but low AHI and an increased number of oxygen desaturations especially during rapid eye movement sleep. Blood pressure responses to episodes of obstructive apnea are augmented in normal pregnancy and further in preeclampsia. The increased sympathetic activity during the third trimester contributes to the increased prevalence of OSA, which in turn probably further augments sympathetic tone and predisposes to preeclampsia (67). Nasal CPAP treatment alleviated sleep-induced blood pressure increases and upper airway collapsibility (67) and improved fetal movement activity (68) in preeclampsia.

Depression is more frequently observed in female OSA patients compared with male patients which may at least partly explain the higher degree of daytime fatigue and sleepiness in female patients with low degree of OSA. Sforza et al. (69) reported that women with OSA had five-fold increased risk of having depression compared to men (11.9% vs. 2.7%). Depression did not correlate with AHI but it did with the time with SaO2 below 90% and with the mean SaO2. Episodes of partial obstruction are often associated with prolonged mild steady state lowering of the SaO2. Therefore it is possible that in the absence of correlation with AHI, partial obstruction (not measured in their study) could have contributed to these correlations. Fatigue and sleepiness are symptoms of depression but so are insomnia and anxiety. Depression is not a single entity but includes a variety of different phenotypes. Fatigue and sleepiness are common symptoms in atypical depression, but the biological mechanisms of these symptoms are not known. Partial obstruction with increased CO2 levels during sleep could be one such mechanism, since 12 weeks of therapy with CPAP controlling both AHI and partial obstruction even in women with moderate severity of sleep apnea results in improvement of quality of life, daytime sleepiness, mood state, anxiety, and depression symptoms (70).

CPAP adherence

Partial upper airway obstruction should not be considered as ‘simple snoring’ or mild OSA, which are associated with lower adherence to nasal CPAP therapy (71). Partial upper airway obstruction, even in the absence of episodes of apnea or hypopnea, highly predicts good CPAP adherence and efficient relief of symptoms with nasal CPAP therapy (12, 72). Prolonged flow limitation has been evaluated in stepwise CPAP titration studies. The contour of inspiratory flow appears as the simplest variable that best correlates with lowest esophageal pressure during CPAP titration (73). Prolonged flow limitation also seems to be the earliest indicator of obstruction, even more sensitive than snoring, during decreases in CPAP pressure (74). Though treatment of symptomatic partial upper airway obstruction is not suggested by guidelines but it has been our clinical practice since the nasal CPAP became available (1987). This has been based on the knowledge about flow limitation (75) and recognition of prolonged partial obstruction with mattress sensors.

An AHI of more than five per hour is considered significant for diagnosis of OSA but often higher AHI is required for initiation of nasal CPAP therapy. Sleepy patients with low AHI, with non-apneic snoring should not be overlooked. Considering increased fatigue in women with OSA despite low or normal AHI, it has been suggested that treatment should be considered in symptomatic women with snoring or partial upper airway obstruction even if AHI<5/h (17, 58). This approach is supported by good CPAP adherence in patients with predominantly partial obstruction (12, 72). If the patient is compliant to the CPAP therapy and becomes symptomless during the follow-up, it is our clinical practice to continue with the CPAP therapy as a long-term treatment.

For women in particular, it is important that the CPAP is titrated to control not only obstructive sleep apnea but also episodes of partial upper airway obstruction. Recent female-specific autotitrating algorithms for CPAP devices may reduce flow limitation more efficiently but whether this results in better treatment outcome, remains to be seen (76).

Conclusions

Particularly in women, the upper airway obstruction often manifests as non-countable non-apneic respiratory events (snoring, flow limitation or partial upper airway obstruction) (11, 12). Failure to recognize prolonged partial obstruction in sleep studies may lead to under recognition of SDB especially in women (56, 77). Partial obstruction, even in the absence of episodes of apnea, may cause clinically significant symptoms. Patients with symptomatic partial upper airway obstruction respond and adhere to nasal CPAP therapy at least as well as those with ‘conventional’ OSAS (12, 72). The scarce available data suggest that despite less severe OSA in females, the consequences of OSA might not be less severe. Therefore, identifying the phenotype of partial upper airway obstruction during sleep may lead to timely and appropriate therapy especially in female patients and might also reduce lost work days among them (78, 79).

Authors’ contributions

All authors contributed to writing of this article, read, and approved the final version of this manuscript.

References

  1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046–53. Publisher Full Text
  2. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med. 2012; 156: 115–22. Publisher Full Text
  3. Tkacova R, McNicholas WT, Javorsky M, Fietze I, Sliwinski P, Parati G, et al. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study. Eur Respir J. 2014; 44: 931–41. Publisher Full Text
  4. Kent BD, Grote L, Ryan S, Pepin JL, Bonsignore MR, Tkacova R, et al. Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest. 2014; 146: 982–90. Publisher Full Text
  5. Kent BD, Grote L, Bonsignore MR, Saaresranta T, Verbraecken J, Levy P, et al. Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study. Eur Respir J. 2014; 44: 130–9. Publisher Full Text
  6. Berry RB, Brooks R, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV. The AASM manual for the scoring of sleep and associated events; rules, terminology and technical specifications. Darien, IL: American Academy of Sleep Medicine; 2012.
  7. Hudgel DW. ‘Apnea index’: need for improving the description of respiratory variability during sleep. Am Rev Respir Dis. 1986; 133: 708–9.
  8. Polo O, Brissaud L, Sales B, Besset A, Billiard M. The validity of the static charge sensitive bed in detecting obstructive sleep apnoeas. Eur Respir J. 1988; 1: 330–6.
  9. Polo OJ, Tafti M, Fraga J, Porkka KV, Dejean Y, Billiard M. Why don’t all heavy snorers have obstructive sleep apnea? Am Rev Respir Dis. 1991; 143: 1288–93. Publisher Full Text
  10. Tenhunen M, Elomaa E, Sistonen H, Rauhala E, Himanen SL. Emfit movement sensor in evaluating nocturnal breathing. Respir Physiol Neurobiol. 2013; 187: 183–9. Publisher Full Text
  11. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342: 1378–84. Publisher Full Text
  12. Anttalainen U, Saaresranta T, Kalleinen N, Aittokallio J, Vahlberg T, Polo O. CPAP adherence and partial upper airway obstruction during sleep. Sleep Breath. 2007; 11: 171–6. Publisher Full Text
  13. Polo-Kantola P, Rauhala E, Helenius H, Erkkola R, Irjala K, Polo O. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol. 2003; 102: 68–75.
  14. Rauhala E, Himanen SL, Saastamoinen A, Polo O. Prolonged spiking in the Emfit sensor in patients with sleep-disordered breathing is characterized by increase in transcutaneous carbon dioxide. Physiol Meas. 2007; 28: 1163–73. Publisher Full Text
  15. Rimpilä V, Hosokawa K, Huhtala H, Saaresranta T, Salminen AV, Polo O. Transcutaneous carbon dioxide during sleep-disordered breathing. Respir Physiol Neurobiol. 2015; 219: 95–102. Publisher Full Text
  16. Tenhunen M, Rauhala E, Virkkala J, Polo O, Saastamoinen A, Himanen SL. Increased respiratory effort during sleep is non-invasively detected with movement sensor. Sleep Breath. 2011; 15: 737–46. Publisher Full Text
  17. Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest. 1993; 104: 781–7. Publisher Full Text
  18. Schwartz AR, Smith PL, Wise RA, Gold AR, Permutt S. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985). 1988; 64: 535–42.
  19. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993; 328: 303–7. Publisher Full Text
  20. Carberry JC, Jordan AS, White DP, Wellman A, Eckert DJ. Upper airway collapsibility (Pcrit) and pharyngeal dilator muscle activity are sleep stage dependent. Sleep. 2016; 39: 511–21. Publisher Full Text
  21. Henke KG, Dempsey JA, Kowitz JM, Skatrud JB. Effects of sleep-induced increases in upper airway resistance on ventilation. J Appl Physiol (1985) 1990; 69: 617–24.
  22. Lo YL, Jordan AS, Malhotra A, Wellman A, Heinzer RC, Schory K, et al. Genioglossal muscle response to CO2 stimulation during NREM sleep. Sleep. 2006; 29: 470–7.
  23. Schneider H, Krishnan V, Pichard LE, Patil SP, Smith PL, Schwartz AR. Inspiratory duty cycle responses to flow limitation predict nocturnal hypoventilation. Eur Respir J. 2009; 33: 1068–76. Publisher Full Text
  24. Stoohs R, Guilleminault C. Snoring during NREM sleep: respiratory timing, esophageal pressure and EEG arousal. Respir Physiol. 1991; 85: 151–67. Publisher Full Text
  25. Hoshino Y, Ayuse T, Kurata S, Ayuse T, Schneider H, Kirkness JP, et al. The compensatory responses to upper airway obstruction in normal subjects under propofol anesthesia. Respir Physiol Neurobiol. 2009; 166: 24–31. Publisher Full Text
  26. Rimpilä V, Saaresranta T, Huhtala H, Virkki A, Salminen AV, Polo O. Transcutaneous CO(2) plateau as set-point for respiratory drive during upper airway flow-limitation. Respir Physiol Neurobiol. 2014; 191: 44–51. Publisher Full Text
  27. Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985). 1988; 64: 789–95.
  28. Patil SP, Schneider H, Marx JJ, Gladmon E, Schwartz AR, Smith PL. Neuromechanical control of upper airway patency during sleep. J Appl Physiol (1985). 2007; 102: 547–56. Publisher Full Text
  29. Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D. Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med. 2001; 164: 250–5. Publisher Full Text
  30. Calero G, Farre R, Ballester E, Hernandez L, Daniel N, Montserrat Canal JM. Physiological consequences of prolonged periods of flow limitation in patients with sleep apnea hypopnea syndrome. Respir Med. 2006; 100: 813–7. Publisher Full Text
  31. Anttalainen U, Saaresranta T, Aittokallio J, Kalleinen N, Vahlberg T, Virtanen I, et al. Impact of menopause on the manifestation and severity of sleep-disordered breathing. Acta Obstet Gynecol Scand. 2006; 85: 1381–8. Publisher Full Text
  32. Condos R, Norman RG, Krishnasamy I, Peduzzi N, Goldring RM, Rapoport DM. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med. 1994; 150: 475–80. Publisher Full Text
  33. Montserrat JM, Farre R, Ballester E, Felez MA, Pasto M, Navajas D. Evaluation of nasal prongs for estimating nasal flow. Am J Respir Crit Care Med. 1997; 155: 211–5. Publisher Full Text
  34. Ayappa I, Rapoport DM. The upper airway in sleep: physiology of the pharynx. Sleep Med Rev. 2003; 7: 9–33. Publisher Full Text
  35. Aittokallio T, Nevalainen O, Pursiheimo U, Saaresranta T, Polo O. Classification of nasal inspiratory flow shapes by attributed finite automata. Comput Biomed Res. 1999; 32: 34–55. Publisher Full Text
  36. Aittokallio T, Saaresranta T, Polo-Kantola P, Nevalainen O, Polo O. Analysis of inspiratory flow shapes in patients with partial upper-airway obstruction during sleep. Chest. 2001; 119: 37–44. Publisher Full Text
  37. Bao G, Guilleminault C. Upper airway resistance syndrome – one decade later. Curr Opin Pulm Med. 2004; 10: 461–7. Publisher Full Text
  38. Hernandez L, Ballester E, Farre R, Badia JR, Lobelo R, Navajas D, et al. Performance of nasal prongs in sleep studies: spectrum of flow-related events. Chest. 2001; 119: 442–50. Publisher Full Text
  39. Johnson PL, Edwards N, Burgess KR, Sullivan CE. Detection of increased upper airway resistance during overnight polysomnography. Sleep. 2005; 28: 85–90.
  40. Heitman SJ, Atkar RS, Hajduk EA, Wanner RA, Flemons WW. Validation of nasal pressure for the identification of apneas/hypopneas during sleep. Am J Respir Crit Care Med. 2002; 166: 386–91. Publisher Full Text
  41. Lorino AM, Lorino H, Dahan E, d’Ortho MP, Coste A, Harf A, et al. Effects of nasal prongs on nasal airflow resistance. Chest. 2000; 118: 366–71. Publisher Full Text
  42. Knaack L, Blum HC, Hohenhorst W, Ryba J, Guilleminault C, Stoohs RA. Comparison of diaphragmatic EMG and oesophageal pressure in obstructed and unobstructed breathing during sleep. Somnologie. 2005; 9: 159–65. Publisher Full Text
  43. Chokroverty S. Sleep disorders medicine: basic science, technical considerations, and clinical aspects. Boston: Butterworth-Heinemann; 1994.
  44. Farre R, Montserrat JM, Navajas D. Noninvasive monitoring of respiratory mechanics during sleep. Eur Respir J. 2004; 24: 1052–60. Publisher Full Text
  45. Vandenbussche NL, Overeem S, van Dijk JP, Simons PJ, Pevernagie DA. Assessment of respiratory effort during sleep: esophageal pressure versus noninvasive monitoring techniques. Sleep Med Rev. 2015; 24: 28–36. Publisher Full Text
  46. Tenhunen M, Hasan J, Himanen SL. Assessment of respiratory effort during sleep with noninvasive techniques. Sleep Med Rev. 2015; 24: 103–4. Publisher Full Text
  47. Kirjavainen T, Polo O, McNamara S, Vaahtoranta K, Sullivan CE. Respiratory challenge induces high frequency spiking on the static charge sensitive bed (SCSB). Eur Respir J. 1996; 9: 1810–5. Publisher Full Text
  48. Alihanka J. Basic principles for analysing and scoring Bio-Matt (SCSB) recordings. Vol. D26. Typopress Oy. Turku: University of Turku; 1987, pp. 1–129.
  49. Cracowski C, Pepin JL, Wuyam B, Levy P. Characterization of obstructive nonapneic respiratory events in moderate sleep apnea syndrome. Am J Respir Crit Care Med. 2001; 164: 944–8. Publisher Full Text
  50. Palombini LO, Tufik S, Rapoport DM, Ayappa IA, Guilleminault C, de Godoy LB, et al. Inspiratory flow limitation in a normal population of adults in Sao Paulo, Brazil. Sleep. 2013; 36: 1663–8.
  51. Anttalainen U, Saaresranta T, Kalleinen N, Aittokallio J, Vahlberg T, Polo O. Gender differences in age and BMI distributions in partial upper airway obstruction during sleep. Respir Physiol Neurobiol. 2007; 159: 219–26. Publisher Full Text
  52. O’Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med. 2000; 161: 1465–72. Publisher Full Text
  53. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328: 1230–5. Publisher Full Text
  54. Guilleminault C, Black JE, Palombini L, Ohayon M. A clinical investigation of obstructive sleep apnea syndrome (OSAS) and upper airway resistance syndrome (UARS) patients. Sleep Med. 2000; 1: 51–6. Publisher Full Text
  55. Mohsenin V. Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions. Chest. 2001; 120: 1442–7. Publisher Full Text
  56. Young T, Hutton R, Finn L, Badr S, Palta M. The gender bias in sleep apnea diagnosis. Are women missed because they have different symptoms? Arch Intern Med. 1996; 156: 2445–51. Publisher Full Text
  57. Valipour A, Lothaller H, Rauscher H, Zwick H, Burghuber OC, Lavie P. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep. 2007; 30: 312–9.
  58. Svensson M, Franklin KA, Theorell-Haglow J, Lindberg E. Daytime sleepiness relates to snoring independent of the apnea-hypopnea index in women from the general population. Chest. 2008; 134: 919–24. Publisher Full Text
  59. Anttalainen U, Polo O, Vahlberg T, Saaresranta T. Women with partial upper airway obstruction are not less sleepy than those with obstructive sleep apnea. Sleep Breath. 2013; 17: 873–6. Publisher Full Text
  60. Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003; 177: 385–90. Publisher Full Text
  61. Anttalainen U, Polo O, Saaresranta T. Is ‘MILD’ sleep-disordered breathing in women really mild? Acta Obstet Gynecol Scand. 2010; 89: 605–11. Publisher Full Text
  62. Chan CS, Bye PT, Woolcock AJ, Sullivan CE. Eucapnia and hypercapnia in patients with chronic airflow limitation. The role of the upper airway. Am Rev Respir Dis. 1990; 141: 861–5. Publisher Full Text
  63. Guilleminault C, Stoohs R, Shiomi T, Kushida C, Schnittger I. Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension. Chest. 1996; 109: 901–8. Publisher Full Text
  64. Lofaso F, Coste A, Gilain L, Harf A, Guilleminault C, Goldenberg F. Sleep fragmentation as a risk factor for hypertension in middle-aged nonapneic snorers. Chest. 1996; 109: 896–900. Publisher Full Text
  65. Anttalainen U, Polo O, Vahlberg T, Saaresranta T. Reimbursed drugs in patients with sleep-disordered breathing: a static-charge-sensitive bed study. Sleep Med. 2010; 11: 49–55. Publisher Full Text
  66. Tenhunen M, Hyttinen J, Lipponen JA, Virkkala J, Kuusimaki S, Tarvainen MP, et al. Heart rate variability evaluation of Emfit sleep mattress breathing categories in NREM sleep. Clin Neurophysiol. 2015; 126: 967–74. Publisher Full Text
  67. Edwards N, Middleton PG, Blyton DM, Sullivan CE. Sleep disordered breathing and pregnancy. Thorax. 2002; 57: 555–8. Publisher Full Text
  68. Blyton DM, Skilton MR, Edwards N, Hennessy A, Celermajer DS, Sullivan CE. Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep. 2013; 36: 15–21.
  69. Sforza E, Saint MM, Barthelemy JC, Roche F. Mood disorders in healthy elderly with obstructive sleep apnea: a gender effect. Sleep Med. 2016; 19: 57–62. Publisher Full Text
  70. Campos-Rodriguez F, Queipo-Corona C, Carmona-Bernal C, Jurado-Gamez B, Cordero-Guevara J, Reyes-Nunez N, et al. Continuous positive airway pressure improves quality of life in women with OSA. A randomized-controlled trial. Am J Respir Crit Care Med. 2016. [Epub ahead of print].
  71. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med. 1999; 159: 461–7. Publisher Full Text
  72. Myllylä M, Kurki S, Anttalainen U, Saaresranta T, Laitinen T. High adherence to CPAP treatment does not prevent the continuation of weight gain among severely obese OSAS patients. J Clin Sleep Med. 2015; 12: 519–28.
  73. Montserrat JM, Ballester E, Olivi H, Reolid A, Lloberes P, Morello A, et al. Time-course of stepwise CPAP titration. Behavior of respiratory and neurological variables. Am J Respir Crit Care Med. 1995; 152: 1854–9. Publisher Full Text
  74. Ayappa I, Norman RG, Hosselet JJ, Gruenke RA, Walsleben JA, Rapoport DM. Relative occurrence of flow limitation and snoring during continuous positive airway pressure titration. Chest. 1998; 114: 685–90. Publisher Full Text
  75. Arora N, Meskill G, Guilleminault C. The role of flow limitation as an important diagnostic tool and clinical finding in mild sleep-disordered breathing. Sleep Sci. 2015; 8: 134–42. Publisher Full Text
  76. McArdle N, King S, Shepherd K, Baker V, Ramanan D, Ketheeswaran S, et al. Study of a novel APAP algorithm for the treatment of obstructive sleep apnea in women. Sleep. 2015; 38: 1775–81. Publisher Full Text
  77. Guilleminault C, Stoohs R, Kim YD, Chervin R, Black J, Clerk A. Upper airway sleep-disordered breathing in women. Ann Intern Med. 1995; 122: 493–501. Publisher Full Text
  78. Sjösten N, Vahtera J, Salo P, Oksanen T, Saaresranta T, Virtanen M, et al. Increased risk of lost workdays prior to the diagnosis of sleep apnea. Chest. 2009; 136: 130–6. Publisher Full Text
  79. Sjösten N, Kivimaki M, Oksanen T, Salo P, Saaresranta T, Virtanen M, et al. Obstructive sleep apnoea syndrome as a predictor of work disability. Respir Med. 2009; 103: 1047–55. Publisher Full Text
About The Authors

Ulla Anttalainen
Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland Sleep Research Centre, Department of Physiology, University of Turku, Turku, Finland
Finland

Mirja Tenhunen
Department of Clinical Neurophysiology, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Tampere, Finland Department of Medical Physics, Tampere University Hospital, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Tampere, Finland
Finland

Ville Rimpilä
School of Medicine, University of Tampere, Tampere, Finland
Finland

Olli Polo
Unesta Research Center, Tampere, Finland Department of Pulmonary Diseases, Tampere University Hospital, Tampere, Finland
Finland

Esa Rauhala
Department of Clinical Neurophysiology, Satakunta Hospital District, Pori, Finland
Finland

Sari-Leena Himanen
Dr. Himanen has nothing to disclose.
Finland

Tarja Saaresranta
Division of Medicine, Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland Sleep Research Centre, Department of Physiology, University of Turku, Turku, Finland
Finland

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Related Content